Altimmune, Inc.
Altimmune, Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | Recruiting | Phase 3 | 2026-09-23 | NCT07795164 | |
| RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD) | Alcohol-associated Liver Disease | Active, not recruiting | Phase 2 | 2026-08-17 | NCT07009860 |